吳斌主管藥師
上海交通大學(xué)醫(yī)學(xué)院附屬仁濟(jì)醫(yī)院藥劑科
擅長領(lǐng)域:?
執(zhí)業(yè)經(jīng)歷: 職 稱:副研究員 職 務(wù):藥學(xué)部主任助理 院 區(qū):東院 科 室:藥劑科 醫(yī)療專長:自獲得第一個上海市教委優(yōu)秀青年教師科學(xué)基金開始(2009年),將研究集中具有用藥復(fù)雜、社會負(fù)擔(dān)重的疾病為研究對象,以運(yùn)籌統(tǒng)計(jì)和臨床決策為研究手段,以評價(jià)和比較不同治療藥物的成本及效果效用為目標(biāo)開展工作。 教育經(jīng)歷 2013/09 – 2014/09,多倫多大學(xué)Leslie Dan藥學(xué)院與多倫多大學(xué)附屬總醫(yī)院(學(xué)習(xí)) 2005/09 – 2008/06,上海交通大學(xué),博士 2002/09 – 2005/06,中國科學(xué)院上海藥物研究所,碩士, 1997/09 – 2002/06,南京醫(yī)科大學(xué) 本科 論文著作 1.期刊論文(SCI收錄第一作者/通訊作者): [1]. Wu B, Dong B, Xu Y, Zhang Q, Shen J, Chen H, Xue W: Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting. PLoS One 2012, 7(3):e32530. (IF = 3.73) [2]. Wu B, Chen H, Shen J, Ye M: Cost-Effectiveness of Adding Rh-Endostatin to First-Line Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer in China. Clin Ther 2011, 33(10):1446-1455. (IF = 2.23) [3]. Wu B, Ye M, Chen H, Shen JF: Costs of Trastuzumab in Combination With Chemotherapy for HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: An Economic Evaluation in the Chinese Context. Clin Ther 2012, 34(2):468-479. (IF = 2.23) [4]. Wu B, Miao Y, Bai Y, Ye M, Xu Y, Chen H, Shen J, Qiu Y: Subgroup economic analysis for glioblastoma in a health resource-limited setting. PLoS One 2012, 7(4):e34588. (IF = 3.73) [5]. Wu B, Li T, Chen H, Shen J: Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis. Value in Health 2010, 13(5):592-600. (IF = 2.191) [6]. Wu B, Wilson A, Wang F-F, Wang S-L, Wallace DJ, Weisman MH, et al. Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in china. PLoS One. 2012; 7(10): e47373. (IF = 3.73) [7]. Y. Bai, M. Ye, H. Cao, X. Ma, Y. Xu and Wu B *. Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting, Breast cancer research and treatment 136 (2012), pp. 547-557. (Corresponding author) (IF = 4.469) [8]. Wu B, J. Shen and H. Cheng, Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China, BMC Health Serv Res 12 (2012), p. 385. (IF = 1.773) [9]. J. Zhu, T. Li, X. Wang, M. Ye, J. Cai, Y. Xu and Wu B *. Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis. BMC Cancer 2013, 13:39. (Corresponding author) (IF = 3.333) [10]. Ben-Juan Wei, Yi-Jun Chen, Li Yu , Wu B. Periodontal Disease and Risk of Preeclampsia: A Meta-Analysis of Observational Studies. PLoS One. 2013. Doi:10.1371/journal.pone.0070901. (IF = 3.73) [11]. Wu B, Kun L, Liu X, He B: Cost-Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2013. 2013 Sep 19. [Epub ahead of print]. PMID: 24048510 (IF = 2.673) 獲得榮譽(yù) ?、?吳斌,林厚文, Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B, 中國藥學(xué)會,優(yōu)秀論文二等獎,2013.11 ?、?吳斌,葉明, Initial Chemotherapy with or without Maintenance Therapy in Patients with Advanced Non-Small-Cell Lung Cancer: An Economic Decision Analysis, 中國藥學(xué)會,優(yōu)秀論文二等獎,2012.11 ?、?吳斌,呂良敬, Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in china, 中華醫(yī)學(xué)會,風(fēng)濕病2012年會優(yōu)秀論文三等獎, 2012.5 ?、?吳斌, 類風(fēng)濕關(guān)節(jié)炎患者使用生物制劑治療的經(jīng)濟(jì)學(xué)研究, 上海市藥學(xué)會,醫(yī)院藥學(xué)2012年會優(yōu)秀論文三等獎, 2012.5 ⑤ 吳斌, Subgroup economic analysis for glioblastoma in a health resource-limited setting, 上海市藥學(xué)會,醫(yī)院藥學(xué)2010年會優(yōu)秀論文一等獎,2010.11 ⑥ 吳斌, 中國乙肝患者使用口服核苷類似物治療的藥物經(jīng)濟(jì)學(xué)研究, 上海交通大學(xué)醫(yī)學(xué)院,醫(yī)院藥學(xué)2010年會優(yōu)秀論文一等獎, 2010.12 ?、?吳斌,邱永明, 腦膠質(zhì)瘤治療的藥物經(jīng)濟(jì)學(xué)決策路徑研究, 中華醫(yī)學(xué)會,國際神經(jīng)外科2010年會優(yōu)秀論文三等獎, 2010.9 ?、?吳斌,沈金芳, Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis, 中國藥學(xué)會,優(yōu)秀論文三等獎,2012.11 詳細(xì)介紹
*以下號源由妙手醫(yī)生專業(yè)認(rèn)證,僅展示近4周號源